RAPP
Rapport Therapeutics, Inc. · Healthcare
CEO Abraham Ceesay sold $285K of Rapport Therapeutics, Inc.
Sold$285,071
$26.12Price
10,916Shares
−2%Stake
What RAPP did after the filing
- The stock from Thu, Jan 22 close, $27.92
- +8.3%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 6 close.
Traded Tue, Jan 20. Filed Thu, Jan 22, 2:00 PM ET, during the session. Returns use the Jan 22 close and the Mar 6 close. Not investment advice.